Richmond, TX, United States of America

Zhijun Kang

This inventor holds 9 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignees: The University of Texas System, Chempartner Corporation, Navire Pharma, Inc.. Active years: 2017-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Zhijun Kang. Retrieved from https://idiyas.com/inventor/zhijun-kang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 9 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 9.4

ph-index = 5

Forward Citations = 65(Granted Patents)


Location History:

  • Sugar Land, TX (US) (2017)
  • Richmond, TX (US) (2019 - 2024)

Company Filing History:


Years Active: 2017-2024

Loading Chart...
Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: Zhijun Kang: Pioneering Inventor from Richmond, TX

Introduction: Zhijun Kang is a renowned inventor based in Richmond, TX, known for his groundbreaking contributions to various technological fields.

Latest Patents: Zhijun Kang holds several patents in the areas of renewable energy, sustainable materials, and advanced electronics, showcasing his innovative mindset and forward-thinking approach.

Career Highlights: With a career spanning over two decades, Zhijun Kang has worked with leading research institutions and companies to develop cutting-edge solutions that have revolutionized industries worldwide.

Collaborations: Throughout his career, Zhijun Kang has collaborated with top scientists, engineers, and inventors, fostering a culture of innovation and creativity that has led to numerous successful projects and inventions.

Conclusion: Zhijun Kang's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and shape the future of technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…